News
UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
Despite the healthcare sector's reputation for stability, UnitedHealth Group (NYSE: UNH) has recently faced significant market turbulence.
By mid-May
Novavax Stock: FDA Approval Triggers Financial Windfall
The U.S. Food and Drug Administration has granted full approval (Biologics License Application) for Novavax's COVID-19 vaccine Nuvaxovid, marking a significant breakthrough for the biotech company
EQS-News: STRATEC BERICHTET ZAHLEN FÜR DAS GESCHÄFTSJAHR 2024
Medicines for Poland: Europa steht vor einer kritischen Entscheidung über Arzneimittel und Marktreformen
Warschau, Polen, May 16, 2025 (GLOBE NEWSWIRE) -- Die Mitgliedstaaten stehen kurz vor dem Abschluss der Diskussionen über die EU-Arzneimittelreform, mit der erschwingliche Medikamente
UnitedHealth Stock: Justice Department Probe Triggers Freefall
UnitedHealth Group finds itself in severe turmoil as shares plummeted nearly 11% to $245.90 following news of a U.S. Justice Department criminal investigation into potential Medicare fraud. The
UnitedHealth Stock: Justice Department Probe Triggers Freefall
UnitedHealth Group finds itself in severe turmoil as shares plummeted nearly 11% to $245.90 following news of a U.S. Justice Department criminal investigation into potential Medicare fraud. The
Polpharma Group fordert dringende Maßnahmen zum Schutz eines frühzeitigen und gerechten Zugangs zu Medikamenten für europäische Patienten
Die Polpharma Group schließt sich dem Aufruf zum Handeln an, um die Arzneimittelreform abzuschließen und eine frühzeitige und nachhaltige Gesundheitsversorgung für europäische Patienten
Big Dippers: 3 Stocks Near 1-Year Lows That Could Surge in 2025
As of mid-May 2025, the S&P 500 has turned positive year-to-date (YTD) for the first time in many weeks. Stocks across multiple sectors have broadly recovered from the jolt of tariff news and
Big Dippers: 3 Stocks Near 1-Year Lows That Could Surge in 2025
As of mid-May 2025, the S&P 500 has turned positive year-to-date (YTD) for the first time in many weeks. Stocks across multiple sectors have broadly recovered from the jolt of tariff news and
Big Dippers: 3 Stocks Near 1-Year Lows That Could Surge in 2025
As of mid-May 2025, the S&P 500 has turned positive year-to-date (YTD) for the first time in many weeks. Stocks across multiple sectors have broadly recovered from the jolt of tariff news and
Merck Stock: Solid Q1 Overshadowed by Lowered Outlook
Merck KGaA delivered impressive first-quarter results for 2025, with net profit climbing 5.5% to €738 million and earnings per share reaching €1.69, representing a 5.6% increase compared to the same
Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer
Insulet Corporation’s (NASDAQ: PODD) recent outperformance has caught investors' attention and has earned it a designation as a top performer on the
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore
Investors searching for high-quality opportunities in the pharmaceutical space should keep a close eye on stocks trading at extremely oversold levels. One of the most popular ways to measure this
Best Biotech Stocks to Buy in 2025
The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered to tell the biotech sector.
Biotech stocks lagged the broader market
Best Biotech Stocks to Buy in 2025
The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered to tell the biotech sector.
Biotech stocks lagged the broader market
Best Biotech Stocks to Buy in 2025
The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered to tell the biotech sector.
Biotech stocks lagged the broader market
EQS-News: Eckert & Ziegler startet mit Ergebniswachstum in Q1 2025 und bestätigt Jahresprognose
EQS-News: Eckert & Ziegler startet mit Ergebniswachstum in Q1 2025 und bestätigt Jahresprognose
EQS-News: Carl Zeiss Meditec erzielt Umsatzwachstum und stabilen operativen Gewinn im ersten Halbjahr 2024/25
EQS-News: Carl Zeiss Meditec erzielt Umsatzwachstum und stabilen operativen Gewinn im ersten Halbjahr 2024/25
EQS-News: Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab
Qualitatives Update erstes Quartal 2025: Tecan meldet Geschäftsgang im Rahmen der Erwartungen und bestätigt den Ausblick für das Gesamtjahr 2025
Ad-hoc-Mitteilung gemäss Artikel 53 des Kotierungsreglements der SIX Swiss Exchange AG
Qualitatives Update erstes Quartal 2025: Tecan meldet Geschäftsgang im Rahmen der Erwartungen und bestätigt
Top Analyst-Rated Healthcare Stocks to Watch Now
It has been a turbulent start to the year for the healthcare industry, as concerns about major cuts to Medicare and Medicaid coincide with the impact of tariffs on supplies and many other
Lonza gibt Ergebnisse der Generalversammlung 2025 bekannt – Alle Anträge des Verwaltungsrates wurden genehmigt
DexCom Stock: Earnings Beat and New Market Access Drive Bull Case
DexCom, Inc. (NASDAQ: DXCM) has once again demonstrated its formidable position in the continuous glucose monitoring (CGM) market, delivering outstanding first-quarter 2025 financial results that